Yusimry Injection, Solution
Product Images NDC 70114-220

Product Visual Gallery

This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Yusimry (NDC 70114-220). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Coherus Biosciences Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Figure 1 (Percent of ACR Responders)

Line graph depicting the percentage of ACR 20 responders over time in weeks for a 40 mg every other week dosage compared to placebo. The solid line represents the 40 mg dose, showing a higher response rate compared to the placebo indicated by a dashed line with open circles.*

FDA Label Image

Image Of Figure 2 (Percent of ASAS 20 Response)

A line graph depicting the percentage of patients achieving an ASAS 20 response over 26 weeks, comparing Adalimumab (208 subjects) to placebo (107 subjects). The x-axis represents time in weeks, and the y-axis shows the percentage response from 0 to 70%. Adalimumab demonstrates a higher and more sustained response compared to placebo throughout the study period.*

FDA Label Image

Image Of Carton (package principal panel)

YUSIMRY (adalimumab-aqvh) Injection 40 mg/0.8 mL single-dose prefilled syringes, labeled for subcutaneous use. The carton contains 2 single-dose prefilled syringes, a medication guide, prescribing information, and instructions for use. Storage instructions specify refrigeration at 36°F to 46°F with protection from light. Labeler is Coherus BioSciences Inc.*

FDA Label Image

Image Of Carton (package principal panel)

YUSIMRY (adalimumab-aqvh) Injection 40 mg/0.8 mL Single-Dose Prefilled Pens carton label. The label states it includes 2 single-dose prefilled pens, 1 medication guide, 1 prescribing information, and 1 instructions for use. It is intended for subcutaneous use only. Storage instructions specify refrigeration at 36° to 46°F and room temperature storage guidelines. The labeler is Coherus BioSciences Inc.*

FDA Label Image

Image Of Removing Yusimiry From Refrigeration (AI instructions for use)

An instructional illustration showing a hand placing a medication box into a refrigerator. A clock nearby indicates a waiting time of 15 to 30 minutes, suggesting the medication should be refrigerated and allowed to reach a certain temperature before use.*

FDA Label Image

Image Of Yusimry Before Use (instructions for use)

Illustration of a syringe for subcutaneous injection, labeled with parts including the plunger, finger grip, and needle cover. The syringe is designed for administering YUSIMRY (adalimumab-aqvh) 40 mg/0.8 mL injection solution.*

FDA Label Image

Image Of Yusimry Pen Status (AI instructions for use)

An instructional illustration showing a close-up view of the fluid window on a syringe or injector pen for injection solution. The magnified inset highlights the presence and level of liquid inside the device, likely indicating correct medication dose or readiness for use.*

FDA Label Image

Image Of Yusimry Removal From Refrigerator (instructions for use)

Illustration showing a hand placing a medication box into a refrigerator, indicating storage instructions for the product YUSIMRY (adalimumab-aqvh) injection, solution, 40 mg/.8 mL, from Coherus BioSciences Inc.*

FDA Label Image

Image Of Yusimry Pen Injection Preparation (AI instructions for use)

An instructional illustration showing step 3 in a process involving an injection device. It depicts a single-use injection pen, a waste disposal container for sharps, a cotton ball or gauze pad, and an inset circular image demonstrating hands being washed under running water from a faucet.*

FDA Label Image

Image Of Sharps Container And Hand Washing (instructions for use)

An instructional illustration showing the proper disposal of a syringe into a labeled sharps container. The image includes a syringe still in its plastic packaging, the sharps container, a vial cap, and an inset demonstrating handwashing under a faucet, emphasizing hygiene after disposal.*

FDA Label Image

Image Of Choosing Injection Site (AI instructions for use)

An instructional diagram illustrating recommended injection sites for a subcutaneous injection. It shows a front view of a person's torso and upper thighs, with labeled areas on the abdomen and thighs as preferred sites. An inset image depicts a hand holding an alcohol prep pad for skin cleansing prior to injection.*

FDA Label Image

Image Of Injectable Areas (instructions for use)

An instructional illustration showing recommended subcutaneous injection sites for YUSIMRY (adalimumab-aqvh) 40 mg/0.8 mL solution. The diagram highlights the abdomen and front thighs as approved injectable areas, alongside a close-up image of a hand holding a sterile swab, indicating site preparation before injection.*

FDA Label Image

Image Of Cap Removal From Yusimry Pen (AI instructions for use)

An instructional illustration showing step 5 of using a prefilled syringe for YUSIMRY (adalimumab-aqvh). It depicts two hands: one holding the syringe and the other removing or attaching the syringe cap, with arrows indicating the direction of movement.*

FDA Label Image

Image Of Cap Removal From Syringe (instructions for use)

An instructional illustration showing two hands holding separate parts of a device, with a double-headed arrow indicating the two parts should be pulled apart or pushed together. This likely depicts assembly or disassembly of a medical injection device for YUSIMRY 40 mg/0.8 mL subcutaneous injection.*

FDA Label Image

Image Of How To Hold Yusimry Pen And Site For Injection (AI instructions for use)

An instructional illustration showing a hand holding a YUSIMRY injection pen at a 90-degree angle to the injection site, demonstrating the correct positioning for subcutaneous injection.*

FDA Label Image

Image Of How To Hold Syringe And Site For Injection (instructions for use)

An instructional illustration showing a hand holding a syringe for subcutaneous injection. A close-up inset highlights the injection site on the skin, indicating proper administration technique for YUSIMRY (adalimumab-aqvh) injection, solution, 40 mg/0.8 mL.*

FDA Label Image

Image Of Press And First Click (AI instructions of use)

An instructional illustration showing a hand holding a YUSIMRY injection device vertically, pressing down to hear the "First Click" as indicated by an arrow and text, demonstrating a step in the subcutaneous injection process for this adalimumab-aqvh 40 mg/.8 mL solution.*

FDA Label Image

Image Of Proper Angle Of Injection (instructions of use)

An instructional illustration showing how to administer a subcutaneous injection of YUSIMRY (adalimumab-aqvh) at a 45-degree angle. It depicts two recommended injection sites: the abdomen or thigh, with a hand holding a syringe positioned accordingly for each site.*

FDA Label Image

Image Of Second Click (AI instructions for use)

An instructional illustration showing a hand holding an injection pen vertically, indicating the step to count to 5 after the second 'Click' sound during administration. A close-up of the injection window on the pen is also shown, highlighting the presence of the solution inside.*

FDA Label Image

Image Of Removal (instructions for use)

An instructional illustration showing a person injecting a subcutaneous injection into the abdominal area using an injection device. The image depicts the final step of the injection process, with an arrow indicating the direction of injection penetration into the skin.*

FDA Label Image

Image Of Proper Pull Away Of Yusimry Pen Post Injection (AI instructions for use)

An instructional illustration showing a hand holding a YUSIMRY autoinjector in an upright position with an arrow indicating upward movement, likely demonstrating part of the injection administration process.*

FDA Label Image

Image Of Proper Sharps Disposal Of Syringe (instructions for use)

An instructional illustration showing a hand disposing of a used syringe into a container labeled 'SHARPS.' The image demonstrates proper disposal of injection equipment to ensure safety and hygiene.*

FDA Label Image

Image Of Disposal Of Used Yusimry Pen (AI instructions for use)

Illustration showing a hand disposing of a syringe into a sharps container, demonstrating safe disposal of injection materials for the YUSIMRY (adalimumab-aqvh) 40 mg/.8 mL subcutaneous injection.*

FDA Label Image

Image Of Marked Calendar (instructions for use)

FDA Label Image

Image Of Before Use And After Use (AI instructions for use)

An instructional diagram showing parts of the YUSIMRY 40 mg/.8mL prefilled pen injection before and after use. Components labeled include the clear cap, needle, gray needle guard, viewing window, gray plunger, prefilled pen body, label with expiration date, and the orange indicator visible after use.*

FDA Label Image

Image Of Marked Calendar (AI instructions for use)

An illustration of a calendar page showing the word "MONTH" at the top, with a grid of squares representing days. One day is circled, indicating a specific date or reminder.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.